Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
SiTime
SITM
$16B
| $3.07M | ﹤0.01% |
26,000
-27,500
| -51% | -$3M |
|
1727
Vera Bradley
VRA
$97M
| $3.06M | ﹤0.01% |
479,702
+278,902
| +139% | +$1.57M |
|
|
OLPX
1728
DELISTED
Olaplex Holdings
OLPX
| $3.06M | ﹤0.01% |
823,300
+197,800
| +32% | +$725K |
|
1729
Disc Medicine
IRON
$2.96B
| $3.06M | ﹤0.01% |
68,890
+53,620
| +351% | +$1.9M |
|
1730
Ligand Pharmaceuticals
LGND
$5.76B
| $3.06M | ﹤0.01% |
42,400
+12,600
| +42% | +$945K |
|
|
ITIC
1731
Investors Title Co
ITIC
$546M
| $3.05M | ﹤0.01% |
20,900
-200
| -0.9% | -$28.3K |
|
1732
Akebia Therapeutics
AKBA
$354M
| $3.05M | ﹤0.01% |
3,330,727
+992,227
| +42% | +$958K |
|
1733
Greif Class B
GEF.B
$4.11B
| $3.04M | ﹤0.01% |
39,419
+14,909
| +61% | +$1.14M |
|
1734
Air T
AIRT
$75.5M
| $3.04M | ﹤0.01% |
121,111
-1,600
| -1% | -$41K |
|
1735
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.3B
| $3.03M | ﹤0.01% |
+85,800
| New | +$3.01M |
|
|
ACB
1736
Aurora Cannabis
ACB
$173M
| $3.02M | ﹤0.01% |
564,583
-16,280
| -3% | -$96K |
|
1737
Transact Technologies
TACT
$53.2M
| $3.01M | ﹤0.01% |
336,237
+16,000
| +5% | +$113K |
|
1738
Gorman-Rupp
GRC
$2.14B
| $3.01M | ﹤0.01% |
104,300
-41,115
| -28% | -$1.05M |
|
1739
SmartFinancial
SMBK
$896M
| $3M | ﹤0.01% |
139,674
+300
| +0.2% | +$6.55K |
|
|
CHMI
1740
Cherry Hill Mortgage Investment Corp
CHMI
$83M
| $2.99M | ﹤0.01% |
619,884
-75,000
| -11% | -$386K |
|
1741
LivePerson
LPSN
$21.8M
| $2.99M | ﹤0.01% |
+44,053
| New | +$2.86M |
|
1742
Oil States International
OIS
$489M
| $2.98M | ﹤0.01% |
399,386
-68,300
| -15% | -$499K |
|
1743
DLH Holdings
DLHC
$70.7M
| $2.98M | ﹤0.01% |
290,927
-18,741
| -6% | -$192K |
|
1744
Planet Fitness
PLNT
$4.42B
| $2.97M | ﹤0.01% |
44,100
+13,800
| +46% | +$989K |
|
|
TDAY
1745
USA Today Co
TDAY
$1.27B
| $2.97M | ﹤0.01% |
1,321,217
+816,617
| +162% | +$1.63M |
|
1746
CION Investment
CION
$297M
| $2.97M | ﹤0.01% |
286,088
-94,112
| -25% | -$928K |
|
1747
PagSeguro Digital
PAGS
$2.69B
| $2.97M | ﹤0.01% |
314,364
-625,975
| -67% | -$6.34M |
|
|
CBAY
1748
DELISTED
Cymabay Therapeutics
CBAY
| $2.96M | ﹤0.01% |
270,020
-211,480
| -44% | -$1.97M |
|
|
RAD
1749
DELISTED
Rite Aid Corporation
RAD
| $2.96M | ﹤0.01% |
1,957,990
+972,900
| +99% | +$1.95M |
|
1750
Mesa Laboratories
MLAB
$564M
| $2.96M | ﹤0.01% |
23,000
+13,300
| +137% | +$2.03M |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.